CHELSEA ZURL: Open Payments
NPI 1497110498 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 32 payments from 11 companies in 2025. Trend: 2023 $2,279 · 2024 $1,884 · 2025 $1,131
Food & beverage: $1,131
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 13 | $494 |
| Boston Scientific Corporation | 3 | $300 |
| Janssen Biotech, Inc. | 3 | $78 |
| PFIZER INC. | 3 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Endo USA, Inc. | 2 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
| UROGEN PHARMA, INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $17 |
Products named: PROVENGE, General - Male SUI, AMS 800 Artificial Urinary Sphincter, XTANDI, ERLEADA, XIAFLEX, ORGOVYX, YONSA.
Industry payments across NC — which companies pay providers there.
